Bio Medica Laboratories (NSE:BMLL) FCF Margin %: -9.66% (As of Mar. 2025)


NSE:BMLL Bio Medica Laboratories Ltd NSE:BMLL
14 GF Score
Price ₹144.10
! 2 Warning Signs
View Full Analysis

What is Bio Medica Laboratories FCF Margin %?

Bio Medica Laboratories NSE:BMLL +0.49% 14 FCF Margin % is -9.66% as of Mar. 2025. GuruFocus rates NSE:BMLL with a GF Score™ of 14/100. The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Bio Medica Laboratories ranks worse than 64.66% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bio Medica Laboratories's Free Cash Flow for the six months ended in Mar. 2025 was ₹-36.9 Mil. Bio Medica Laboratories's Revenue for the six months ended in Mar. 2025 was ₹382.0 Mil. Therefore, Bio Medica Laboratories's FCF Margin % for the quarter that ended in Mar. 2025 was -9.66%.

As of today, Bio Medica Laboratories's current FCF Yield % is -2.04%.

The historical rank and industry rank for Bio Medica Laboratories's FCF Margin % or its related term are showing as below:

NSE:BMLL' s FCF Margin % Range Over the Past 10 Years
Min: -9.66   Med: 0.52   Max: 3.59
Current: -9.66

During the past 3 years, the highest FCF Margin % of Bio Medica Laboratories was 3.59%. The lowest was -9.66%. And the median was 0.52%.

NSE:BMLL's FCF Margin % is ranked worse than
64.66% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.34 vs NSE:BMLL: -9.66

Bio Medica Laboratories FCF Margin % Related Terms

Bio Medica Laboratories FCF Margin % Historical Data

* Premium members only.

The historical data trend for Bio Medica Laboratories's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bio Medica Laboratories FCF Margin % Chart

Bio Medica Laboratories Annual Data
Trend Mar23 Mar24 Mar25
FCF Margin %
3.59 0.52 -9.66

Bio Medica Laboratories Semi-Annual Data
Mar23 Mar24 Mar25
FCF Margin % 3.59 0.52 -9.66

NSE:BMLL vs ISRG, BDX, MDLN: FCF Margin % Comparison

For the Medical Instruments & Supplies subindustry, Bio Medica Laboratories's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio Medica Laboratories FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio Medica Laboratories's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bio Medica Laboratories's FCF Margin % falls into.


NSE:BMLL
14GF Score
Bio Medica Laboratories Ltd NSE:BMLL
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bio Medica Laboratories FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bio Medica Laboratories's FCF Margin for the fiscal year that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-36.911/381.952
=-9.66 %

Bio Medica Laboratories's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-36.911/381.952
=-9.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -9.66% mean?
Bio Medica Laboratories (NSE:BMLL) has a FCF Margin % of -9.66% as of Mar. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bio Medica Laboratories and its competitors. According to the industry distribution chart, Bio Medica Laboratories ranks #527 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 64.7%.
Is Bio Medica Laboratories' FCF Margin % too high?
Bio Medica Laboratories' current FCF Margin % is -9.66%. Based on the distribution chart, Bio Medica Laboratories ranks #527 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Bio Medica Laboratories has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Bio Medica Laboratories' FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Bio Medica Laboratories ranks #527 out of 815 companies for FCF Margin %. This places Bio Medica Laboratories in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Bio Medica Laboratories and its competitors. Bio Medica Laboratories's current FCF Margin % is -9.66%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio Medica Laboratories stock overvalued right now?
Bio Medica Laboratories (NSE:BMLL) has a current FCF Margin % of -9.66%. The current FCF Margin % is -9.66%. Bio Medica Laboratories' overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Bio Medica Laboratories (NSE:BMLL), the current FCF Margin % is -9.66% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bio Medica Laboratories Business Description

Address Sanwer Road, Plot No. 11B-11C, Sector-E, Industrial Area, Industrial Estate - Indore, Indore, MP, IND, 452015
Bio Medica Laboratories Ltd is engaged in the manufacturing of Pharmaceutical Parenteral Formulations. It manufactures generic drugs in the form of injectables namely Liquid Injections and Dry Powder Injections. These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs. Its products address a wide range of medical needs and preferences. The majority of revenue is derived from the sales of Liquid injections. Geographically, it operates predominantly in India, and internationally, it exports to Afghanistan.
14GF Score

Get the complete analysis for NSE:BMLL

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹144.10
Price